Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Edwards' Sapien heart valve:

This article was originally published in Clinica

Executive Summary

Edwards Lifesciences has CE-marked for sale in Europe its Sapien transcatheter aortic heart valve technology with the RetroFlex transfemoral delivery system. The Irvine, California firm intends to begin selling the device in the fourth quarter of 2007. The Sapien bovine pericardial valve is implanted via a minimally-invasive procedure, and is designed to treat patients with severe aortic heart valve stenosis, who are considered to be high-risk or non-operable for conventional open-heart valve replacement surgery. With the RetroFlex transfemoral delivery system, the Sapien valve is compressed onto a balloon to the approximate diameter of a pencil, and is threaded through the patient's circulatory system from the leg and expanded securely into place directly over the diseased aortic valve.

Advertisement
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT049713

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel